Technical Analysis for ETON - Eton Pharmaceutcials, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.09 | 0.82% | 0.03 |
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Death Cross | Bearish | 0.82% | |
| Lower Bollinger Band Walk | Weakness | 0.82% | |
| Inside Day | Range Contraction | 0.82% | |
| Down 3 Days in a Row | Weakness | 0.82% | |
| Down 4 Days in a Row | Weakness | 0.82% | |
| Down 5 Days in a Row | Weakness | 0.82% | |
| Oversold Stochastic | Weakness | 0.82% | |
| Lower Bollinger Band Walk | Weakness | -1.75% | |
| Down 3 Days in a Row | Weakness | -1.75% | |
| Down 4 Days in a Row | Weakness | -1.75% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 2 hours ago |
| 1.5x Volume Pace | about 2 hours ago |
| Fell Below Previous Day's Low | about 3 hours ago |
| Up 2% | about 3 hours ago |
| Up 1% | about 3 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/09/2024
Eton Pharmaceutcials, Inc. Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Pain Pharmaceutical Products Ophthalmic Pain Management Seizure Allergic Conjunctivitis Mimics Ophthalmic Product Ophthalmic Products Liquid Products Parenteral Nutrition
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.81 |
| 52 Week Low | 2.42 |
| Average Volume | 64,618 |
| 200-Day Moving Average | 4.03 |
| 50-Day Moving Average | 4.02 |
| 20-Day Moving Average | 3.55 |
| 10-Day Moving Average | 3.35 |
| Average True Range | 0.21 |
| RSI (14) | 24.81 |
| ADX | 20.01 |
| +DI | 14.70 |
| -DI | 26.19 |
| Chandelier Exit (Long, 3 ATRs) | 3.47 |
| Chandelier Exit (Short, 3 ATRs) | 3.66 |
| Upper Bollinger Bands | 4.04 |
| Lower Bollinger Band | 3.05 |
| Percent B (%b) | 0.01 |
| BandWidth | 27.78 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.22 |
| MACD Histogram | -0.029 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.27 | ||||
| Resistance 3 (R3) | 3.29 | 3.25 | 3.24 | ||
| Resistance 2 (R2) | 3.25 | 3.19 | 3.24 | 3.22 | |
| Resistance 1 (R1) | 3.15 | 3.16 | 3.13 | 3.13 | 3.21 |
| Pivot Point | 3.11 | 3.11 | 3.10 | 3.10 | 3.11 |
| Support 1 (S1) | 3.01 | 3.05 | 2.99 | 2.99 | 2.91 |
| Support 2 (S2) | 2.97 | 3.02 | 2.96 | 2.90 | |
| Support 3 (S3) | 2.87 | 2.97 | 2.89 | ||
| Support 4 (S4) | 2.85 |
